Literature DB >> 34448907

CYP2D6 genetic variation in Ugandans.

Jun Miura1,2, Celestino Obua3, Catherine Abbo4, Tomonori Tateishi5, Sunao Kaneko6.   

Abstract

Entities:  

Keywords:  Africa; Cytochrome P450 2D6 (CYP2D6); Genetic variation; Poor metaboliser; Uganda; Ultrarapid metaboliser

Mesh：

Substances：

Year:  2021        PMID： 34448907     DOI： 10.1007/s00228-021-03208-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism.

Authors:  Andrea Gaedigk; Darren L Ryder; L DiAnne Bradford; J Steven Leeder
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

2.  Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.

Authors:  A Gaedigk; R R Gotschall; N S Forbes; S D Simon; G L Kearns; J S Leeder
Journal:  Pharmacogenetics       Date:  1999-12

Review 3.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

Review 4.  Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry.

Authors:  Joseph P Jarvis; Arul Prakasam Peter; Jeffrey A Shaman
Journal:  Front Psychiatry       Date:  2019-06-20       Impact factor: 4.157

5.  Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.

Authors:  Kelly E Caudle; Katrin Sangkuhl; Michelle Whirl-Carrillo; Jesse J Swen; Cyrine E Haidar; Teri E Klein; Roseann S Gammal; Mary V Relling; Stuart A Scott; Daniel L Hertz; Henk-Jan Guchelaar; Andrea Gaedigk
Journal:  Clin Transl Sci       Date:  2019-10-24       Impact factor: 4.689
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.